홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
SEER
#3273
Seer, Inc. Class A Common Stock
1.7
2
-16.50%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-16.50%
월간 변동
-9.47%
6달 변화
-16.50%
년간 변동율
-20.74%
이전 종가
2.0
6
Open
1.7
2
Bid
Ask
Low
1.7
2
High
1.7
2
양
15
마켓
주식
헬스케어
SEER
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
58.05 M
59.7 M
60.73 M
55.74 M
—
Valuation ratios
Enterprise value
4.02 B
1.07 B
344.48 M
373.54 M
1.26 B
Price to earnings ratio
-19.5
-3.93
-1.44
-1.66
-6
Price to sales ratio
209.81
23.57
7.43
10.16
32.69
Price to cash flow ratio
29.95
6.01
2.1
3.12
10.68
Price to book ratio
2.76
0.82
0.31
0.44
0.73
Enterprise value to EBITDA ratio
-61.69
-12.03
-4.27
-4.41
-16.35
Profitability ratios
Return on assets %
0.13
0.19
0.2
0.24
0.24
Return on equity %
0.14
0.21
0.22
0.26
0.26
Return on invested capital %
214.16
407.85
495.63
347.13
308.12
Gross margin %
51.56
45.78
51.05
49.79
202.95
Operating margin %
1 080.14
627.61
620.99
706.43
2 056.45
EBITDA margin %
-984.1
-571.61
-484.59
-597.54
-1 706.08
Net margin %
1 075.55
600.05
517.84
611.14
1 939.89
Liquidity ratios
Quick ratio
30.36
34.2
24.66
16.04
67.07
Current ratio
30.67
34.57
25
16.53
69.27
Inventory turnover
—
0.12
0.19
0.03
0.02
Asset turnover
0.01
0.03
0.04
0.04
0.05
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.76
0.97
0.93
0.74
0.76
EBIT per share
-1.17
-1.56
-1.62
-1.61
-1.41
EBITDA per share
-1.07
-1.42
-1.26
-1.36
-1.17
Total debt per share
—
—
—
—
—
Cash per share
8.1
6.83
5.84
4.8
18.42
Net current asset value per share
6.76
6.97
5.18
4.06
15.9
Tangible book value per share
8.26
7.16
6.22
5.25
20.28
Working capital per share
6.54
6.77
4.97
3.82
14.97
Book value per share
8.26
7.16
6.22
5.25
20.09
Seer Inc - Class A
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.
뉴스
Seer, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SEER) 2026-02-27
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Seer 4분기 실적 부진: 설치 기반 67% 급증, 매출은 기대에 못 미쳐
Seer Q4 2025 slides: installed base surges 67%, revenue misses mark
시어 Q4 실적 예상치를 넘어, 수익 에상치보다 저조
Seer earnings beat by $0.02, revenue fell short of estimates
Seer, US HUPO 컨퍼런스에서 프로테오믹스 기술 선보일 예정
Seer to showcase proteomics technology at US HUPO conference
Mass spectrometry study validates protein-gene associations for drug discovery
Seer, Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:SEER) 2025-11-26
Seer, 프로테오믹스 혁신 주도: CG MedTech 포럼
Seer at CG MedTech Forum: Proteomics Innovations Lead the Way